After finishing at $8.98 in the prior trading day, Herbalife Ltd (NYSE: HLF) closed at $8.70, down -3.12%. In other words, the price has decreased by -$0.28 from its previous closing price. On the day, 1240835 shares were traded.
Ratios:
Our goal is to gain a better understanding of HLF by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.46 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 3.88. For the most recent quarter (mrq), Quick Ratio is recorded 0.70 and its Current Ratio is at 1.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, DA Davidson on September 14, 2023, initiated with a Neutral rating and assigned the stock a target price of $13.50.
On June 07, 2023, Mizuho started tracking the stock assigning a Neutral rating and target price of $13.
On February 03, 2023, BofA Securities started tracking the stock assigning a Underperform rating and target price of $14.BofA Securities initiated its Underperform rating on February 03, 2023, with a $14 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 11 ’24 when Macadrai Rodica bought 5,175 shares for $9.31 per share. The transaction valued at 48,179 led to the insider holds 12,716 shares of the business.
Mendoza Juan Miguel bought 4,421 shares of HLF for $40,408 on Mar 11 ’24. The Director now owns 38,543 shares after completing the transaction at $9.14 per share. On Mar 08 ’24, another insider, Mendoza Juan Miguel, who serves as the Director of the company, bought 6,500 shares for $9.14 each. As a result, the insider paid 59,410 and bolstered with 34,122 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HLF now has a Market Capitalization of 896.08M and an Enterprise Value of 3.09B. As of this moment, Herbalife’s Price-to-Earnings (P/E) ratio for their current fiscal year is 6.12, and their Forward P/E ratio for the next fiscal year is 3.33. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.17. Its current Enterprise Value per Revenue stands at 0.61 whereas that against EBITDA is 6.41.
Stock Price History:
Over the past 52 weeks, HLF has reached a high of $19.48, while it has fallen to a 52-week low of $6.68. The 50-Day Moving Average of the stock is 10.69, while the 200-Day Moving Average is calculated to be 13.33.
Shares Statistics:
The stock has traded on average 1.92M shares per day over the past 3-months and 1.89M shares per day over the last 10 days, according to various share statistics. A total of 99.20M shares are outstanding, with a floating share count of 95.43M. Insiders hold about 3.86% of the company’s shares, while institutions hold 106.08% stake in the company. Shares short for HLF as of Feb 29, 2024 were 13.79M with a Short Ratio of 7.20, compared to 13.44M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 13.89% and a Short% of Float of 16.12%.
Dividends & Splits
The stock’s 5-year Average Dividend Yield is 1.70. The current Payout Ratio is 0.00% for HLF, which recently paid a dividend on Mar 18, 2014 with an ex-dividend date of Feb 28, 2014. Stock splits for the company last occurred on May 15, 2018 when the company split stock in a 2:1 ratio.
Earnings Estimates
Its stock is currently analyzed by 3 different market analysts. On average, analysts expect EPS of $0.39 for the current quarter, with a high estimate of $0.44 and a low estimate of $0.31, while EPS last year was $0.54. The consensus estimate for the next quarter is $0.67, with high estimates of $0.72 and low estimates of $0.63.
Analysts are recommending an EPS of between $2.3 and $1.96 for the fiscal current year, implying an average EPS of $2.11. EPS for the following year is $2.47, with 4 analysts recommending between $2.83 and $2.22.
Revenue Estimates
5 analysts predict $1.24B in revenue for the current quarter. It ranges from a high estimate of $1.27B to a low estimate of $1.22B. As of the current estimate, Herbalife Ltd’s year-ago sales were $1.25B, an estimated decrease of -0.90% from the year-ago figure. For the next quarter, 5 analysts are estimating revenue of $1.32B, an increase of 3.50% over than the figure of -$0.90% in the same quarter last year. There is a high estimate of $1.33B for the next quarter, whereas the lowest estimate is $1.31B.
A total of 5 analysts have provided revenue estimates for HLF’s current fiscal year. The highest revenue estimate was $5.1B, while the lowest revenue estimate was $5.08B, resulting in an average revenue estimate of $5.09B. In the same quarter a year ago, actual revenue was $5.06B, up 0.50% from the average estimate. Based on 5 analysts’ estimates, the company’s revenue will be $5.32B in the next fiscal year. The high estimate is $5.41B and the low estimate is $5.23B. The average revenue growth estimate for next year is up 4.50% from the average revenue estimate for this year.
